Source: Annual Congress 2001 - Inhalation technology and respiratory measurement in disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. Tarsin, O. J. Corrado, K. Brownlee, P. Kanthapillai, S. Pearson, P. Chetcuti, H. Chrystyn (Bradford, Leeds, United Kingdom). Interindividual variability of peak inhalation rate through different inhalers by asthmatic children and adults and those with COPD. Eur Respir J 2001; 16: Suppl. 31, 900

Member's Comments

No comment yet.

Related content which might interest you: Incentive for reduced variability in lung deposition of fluticasone propionate in young asthmatic children Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008 Comparison of the acute effects of salbutamol and terbutaline on heart rate variability in adult asthmatic patients Source: Eur Respir J 2001; 17: 863-867 Year: 2001 Bronchodilator response to different doses of albuterol in asthmatic children Source: Annual Congress 2007 - Crossroads between paediatric respiratory physiology and epidemiology Year: 2007 Differences in inhaler misuse between patients with asthma and COPD. Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 Reduction of respiratory resistance after fluticasone inhaled therapy in asthmatic preschool children Source: Eur Respir J 2004; 24: Suppl. 48, 166s Year: 2004 Comparison of sensitivity and variability of sGaw and FEV1 for measuring bronchodilation in healthy and asthmatic subjects Source: Eur Respir J 2004; 24: Suppl. 48, 338s Year: 2004 Peak inspiratory flow rates through placebo dry powder inhaler device in various asthma and COPD patients Source: Annual Congress 2012 - Asthma management Year: 2012 Respiratory resistance and bronchodilator response in young children with different wheezing phenotypes Source: Eur Respir J 2006; 28: Suppl. 50, 835s Year: 2006 Why do young adults with asthma overuse bronchodilator inhalers? A qualitative study Source: Eur Respir J 2006; 28: Suppl. 50, 572s Year: 2006 Airway resistance variability and response to bronchodilator in children with asthma Source: Eur Respir J 2007; 30: 260-268 Year: 2007 No differences in bronchodilation after inhalation of dry powder β2-agonists in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 493s Year: 2001 Baseline lung function and bronchodilator response in young children with different wheezing phenotypes Source: Annual Congress 2008 - Diagnostic paediatric lung function: technical and clinical aspects Year: 2008 The effect of inhaler switching on asthma and COPD patients Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 Comparison of formoterol and terbutaline for treatment of asthma exacerbations in children and adolescents Source: Eur Respir J 2004; 24: Suppl. 48, 343s Year: 2004 Seasonal variation in COPD exacerbation rates: budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) at two ICS dose levels in the ETHOS trial Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD Year: 2020 Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI Source: Virtual Congress 2020 – New imaging techniques applied to old problems Year: 2020 Change in respiratory admittance induced by bronchodilator in asthmatic young children Source: Eur Respir J 2006; 28: Suppl. 50, 421s Year: 2006 Cardiovascular effects of a high dose of the budesonide/formoterol single inhaler in asthmatic patients Source: Eur Respir J 2001; 18: Suppl. 33, 54s Year: 2001 Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 Efficacy of high dose inhaled DSCG on asthma control in young children Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008